adlitterio66339

About adlitterio66339

This author has not yet filled in any details.
So far adlitterio66339 has created 511 blog entries.

11 02, 2024

Angela Santoro et al., Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs

adlitterio663392024-02-11T14:12:27+01:00

2 02, 2024

Samantha Epistolio et al., Clinical Relevance and Interplay between miRNAs in Influencing Glioblastoma Multiforme Prognosis

adlitterio663392024-02-02T14:31:34+01:00

27 01, 2024

Combination of Maria Cristina Sini et al., Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population

adlitterio663392024-01-27T14:55:35+01:00

19 01, 2024

Marcella Barbarino et al., Comparison of two mechanical disaggregation methods of fresh lung tissues for extraction of high-quality RNA

adlitterio663392024-01-19T14:43:41+01:00

17 01, 2024

Federica Grillo et al., Correction to: Prevalence and type of MMR expression heterogeneity in colorectal adenocarcinoma: therapeutic implications and reporting

adlitterio663392024-04-10T16:57:41+02:00

8 01, 2024

Diatech Pharmacogenetics will attend the Assisés de Génétique Humain et Médicale 2024
Diatech Pharmacogenetics will attend the Assisés de Génétique Humain et Médicale 2024

Events, News

Diatech Pharmacogenetics will attend the Assisés de Génétique Humain et Médicale 2024

adlitterio663392024-01-08T15:26:03+01:00

6 01, 2024

Matteo Pallocca et al., Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres

adlitterio663392024-01-06T14:53:04+01:00

3 01, 2024

Michele Simbolo et al., Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives

adlitterio663392024-04-10T15:44:30+02:00

3 01, 2024

Federica Grillo et al., BRAFV600E immunohistochemistry can reliably substitute BRAF molecular testing in the Lynch syndrome screening algorithm in colorectal cancer

adlitterio663392024-01-03T14:49:53+01:00

1 01, 2024

Andrea Boscolo Bragadin et al., Integrating clinico-pathological features and longitudinal liquid biopsy results to predict clinical benefit from immune checkpoint Inhibitors in advanced Non-Small Cell Lung Cancer patients

adlitterio663392024-01-01T14:40:45+01:00

Previous 123 Next